Additionally, our results were, to some extent, similar to a previous study on the Western population by Li et al., who detected 11.5% BRCA1/2-negative patients out of 660 familial BC patients carrying mutations in the ATM, CHEK2, and PALB2 genes [61]. This evidence concerns the gene PALB2 and breast cancer.